Log In
Sign Up
about
faq
Ask a question
Latest
News
Jobs
Tutorials
Tags
Users
New Post
Latest
News
Jobs
Tutorials
Tags
Users
Log In
Sign Up
About
Limit
all time
today
this week
this month
this year
Unanswered
All posts
Sort
Update
Answers
Bookmarks
Creation
Replies
Rank
Views
Votes
No posts found.
0 results • Page
1 of 1
Recent ...
Replies
Comment: Join BOC Sciences at Drug Discovery Chemistry 2024
by
boltropeuniveraeidug
• 0
How to attend this Drug Discovery Chemistry conference? [doodle baseball](https://doodlebaseball.io/)
Comment: Bioconductor Build System
by
boltropeuniveraeidug
• 0
Has it been restored yet? [Flappy Bird](https://flappy-bird.co/)
Comment: Services
by
boltropeuniveraeidug
• 0
How much does it cost per use of Creative Peptides? [Geometry Dash](https://geometrydash-free.io/)
Comment: Cross-validation with multiple control subgroups in limma
by
Ali Barry
▴ 40
Thanks so much for taking the time here, the insights are much appreciated. I suspected I'd have to ad hoc compare results if I did repeat …
Answer: Cross-validation with multiple control subgroups in limma
by
Gordon Smyth
52k
limma doesn't do cross-validation or resampling. Like most classical linear modeling procedures in statistics, limma uses a statistical mod…
Votes
Answer: Can DESeq2's design compensate for sequencing experimental design shortcomings?
Comment: Issues with seqlevelsStyle when making custom txdb objects for genomes/annotatio
C: edgeR and lack of counts ID on CPM matrix
A: DESeq2 Following RSEM
A: importing RSEM data into DESeq2
Awards
• All
Popular Question
to
bpshtiwan
▴ 10
Popular Question
to
Ali Barry
▴ 40
Popular Question
to
gabriel.hoffman
▴ 170
Popular Question
to
Jenny Drnevich
★ 2.0k
Popular Question
to
martin.grigorov
▴ 10
Locations
• All
WEHI, Melbourne, Australia,
29 minutes ago
Bangladesh,
1 hour ago
United States,
2 hours ago
Indonesia,
2 hours ago
Japan,
2 hours ago
Traffic: 578 users visited in the last hour
Content
Search
Users
Tags
Badges
Help
About
FAQ
Access
RSS
API
Stats
Use of this site constitutes acceptance of our
User Agreement and Privacy Policy
.
Powered by the
version 2.3.6